Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weisan Chen

Showing results (171-180 of 175) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 175 results.
Immunity|May 4, 2021
CD8<sup>+</sup> T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronavirusesKatie E Lineburg, Emma J Grant, Srividhya Swaminathan, et al.
Research (Washington, D.C.)|July 18, 2024
<i>Helicobacter pylori</i>-Induced Angiopoietin-Like 4 Promotes Gastric Bacterial Colonization and GastritisRui Xie, Nan You, Wan-Yan Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2004
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humansIan D Davis, Weisan Chen, Heather Jackson, et al.
Journal for Immunotherapy of Cancer|April 23, 2020
Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanomaJonathan S Cebon, Martin Gore, John F Thompson, et al.
Nature Communications|May 12, 2021
Immune cellular networks underlying recovery from influenza virus infection in acute hospitalized patientsThi H O Nguyen, Marios Koutsakos, Carolien E van de Sandt, et al.
Pageof 18

Showing results (171-180 of 175) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 175 results.
Immunity|May 4, 2021
CD8<sup>+</sup> T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronavirusesKatie E Lineburg, Emma J Grant, Srividhya Swaminathan, et al.
Research (Washington, D.C.)|July 18, 2024
<i>Helicobacter pylori</i>-Induced Angiopoietin-Like 4 Promotes Gastric Bacterial Colonization and GastritisRui Xie, Nan You, Wan-Yan Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2004
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humansIan D Davis, Weisan Chen, Heather Jackson, et al.
Journal for Immunotherapy of Cancer|April 23, 2020
Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanomaJonathan S Cebon, Martin Gore, John F Thompson, et al.
Nature Communications|May 12, 2021
Immune cellular networks underlying recovery from influenza virus infection in acute hospitalized patientsThi H O Nguyen, Marios Koutsakos, Carolien E van de Sandt, et al.
Pageof 18